Watch Out Novo, Lilly Is Closing the Gap in the Weight-Loss Drug Race

This week, Q2 earnings from Novo Nordisk and Eli Lilly revealed that the competition between the pharma giants’ weight-loss drugs Wegovy and Zepbound is getting closer.